[Thrombocytopenia following a re-introduction of rifampicin in a daily treatment. Apropos of a case].
Beji
M
M
Service de Pneumologie et d'Allergologie, Centre Hospitalo-Universitaire de la Rabta, Tunis.
Louzir
B
B
Ben Rhomdane
N
N
Zouari
M
M
Mtimet
B
B
Daghfous
J
J
D000328:Adult; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D004334:Drug Administration Schedule; D004342:Drug Hypersensitivity / Q000209:etiology; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011693:Purpura / Q000139:chemically induced; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects*; D013307:Streptomycin / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Thrombocytopénie secondaire à la ré-introduction de rifampicine en traitement quotidien. A propos d'un cas.